Oncology Institute Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -35.9% | -85.9% | -6,533.1% | – | – | – | – | |
| – | +166.8% | +8.0% | +5.1% | +32.0% | +33.1% | +7.0% | +10.5% | |
| – | – | +60.6% | +16,148.3% | +12.8% | -35.7% | -37.4% | -59.2% | |
| – | +80.9% | +750.9% | -28.5% | -722.4% | – | – | – | |
| – | – | -71.2% | -1,560.6% | – | – | +665.5% | -92.7% | |
| – | +73.1% | -0.9% | +155.2% | +81.5% | -17.4% | -17.0% | -15.5% | |
| – | -148.4% | +634.2% | +37.4% | +982.9% | – | -26.2% | -106.7% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | -103.9% | -88.7% | -100.0% | – | |
| – | +0.0% | – | -159.5% | – | -100.1% | -61.4% | +51,276.9% | |
| – | -100.0% | – | +1,195.5% | -40.1% | -107.4% | -49.0% | – | |
| – | – | +47.5% | +2,973.6% | -192.7% | – | -16.9% | -199.5% | |
| – | -51.3% | -128.5% | – | – | – | – | – |
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.